0001562180-19-005412.txt : 20191108 0001562180-19-005412.hdr.sgml : 20191108 20191108170128 ACCESSION NUMBER: 0001562180-19-005412 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191106 FILED AS OF DATE: 20191108 DATE AS OF CHANGE: 20191108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trojer Patrick CENTRAL INDEX KEY: 0001760185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 191204821 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-11-06 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001760185 Trojer Patrick C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 false true false false Chief Scientific Officer Common Stock 2019-11-06 4 M false 195.00 4.08 A 8417.00 D Common Stock 2019-11-06 4 M false 801.00 5.51 A 9218.00 D Common Stock 2019-11-06 4 M false 8641.00 5.51 A 17859.00 D Common Stock 2019-11-06 4 M false 18765.00 5.62 A 36624.00 D Common Stock 2019-11-06 4 M false 5786.00 7.60 A 42410.00 D Common Stock 2019-11-06 4 M false 839.00 7.60 A 43249.00 D Common Stock 2019-11-06 4 M false 2893.00 8.04 A 46142.00 D Common Stock 2019-11-06 4 S false 11535.00 20.0084 D 34607.00 D Common Stock 2019-11-06 4 S false 23072.00 25.0613 D 11535.00 D Common Stock 2019-11-06 4 S false 11535.00 30.1554 D 0.00 D Stock Option (Right to Buy) 8.04 2019-11-06 4 M false 2893.00 0.00 D 2028-04-22 Common Stock 2893.00 43387.00 D Stock Option (Right to Buy) 7.60 2019-11-06 4 M false 839.00 0.00 D 2026-02-18 Common Stock 839.00 850.00 D Stock Option (Right to Buy) 7.60 2019-11-06 4 M false 5786.00 0.00 D 2028-03-05 Common Stock 5786.00 40494.00 D Stock Option (Right to Buy) 5.62 2019-11-06 4 M false 18765.00 0.00 D 2025-11-08 Common Stock 18765.00 2836.00 D Stock Option (Right to Buy) 5.51 2019-11-06 4 M false 8641.00 0.00 D 2027-02-16 Common Stock 8641.00 17312.00 D Stock Option (Right to Buy) 5.51 2019-11-06 4 M false 801.00 0.00 D 2027-07-10 Common Stock 801.00 3121.00 D Stock Option (Right to Buy) 4.08 2019-11-06 4 M false 195.00 0.00 D 2022-03-06 Common Stock 195.00 0.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This option was granted on July 11, 2017, and the shares underlying the options vest in equal quarterly installments through July 11, 2021. This option was granted on March 7, 2012, and is fully vested. This transaction was executed in multiple trades at prices ranging from $20.00 to $20.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $25.00to $25.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on April 23, 2018, and the shares underlying the options vest in equal quarterly installments through April 23, 2022. This option was granted on February 19, 2016, and the shares underlying the options vest in equal quarterly installments through February 19, 2020. This option was granted on March 6, 2018, and the shares underlying the options vest in equal quarterly installments through March 6, 2022. This option was granted on November 9, 2015, and is fully vested. This option was granted on February 17, 2017, and the shares underlying the options vest in equal quarterly installments through February 17, 2021. /s/ Karen Valentine, as attorney-in-fact 2019-11-07